The 1st General Assembly Meeting within the EPISTOP project took place on November 16-17, 2015 in Berlin, Germany. The meeting was moderated by dr. Bernhard Weschke. He is a pediatric neurologist at Charité – Universitätsmedizin Berlin. Representatives of each Partner of EPISTOP project and members of the Scientific Advisory Board attended the meeting.

During this meeting, the progress and issues of each work package were presented. Successful discussions were held about various aspects of the project: recruitment of patients, sampling, protocols, scientific research, administration and dissemination. More specific issues were adressed in the clinical and the molecular group. According to the Scientific Advisory Board members EPISTOP in general is a visionary study.

Currently 65 patients are included in our study so far. We hope to enroll more patients in the next 6 months, since the recruitment period will end in June 2016.